Capitol Investment Corp. IV (NYSE:CIC)
Capitol Investment Corp. IV is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Capitol Investment Corp. IV is based in WASHINGTON, United States.
Capitol Investment Corp. IV (NYSE:CIC)’s Financial Overview
Capitol Investment Corp. IV (NYSE) surged 0% yesterday to close its trading session at $9.99. Capitol Investment Corp. IV has 52-Week high of $10.06 and 52-Week Low of $9.65. The stock touched its 52-Week High on 10.06 and 52-Week Low on 9.65. The stock traded with the volume of 125524 shares yesterday. The firm shows the market capitalization of $19.06 Million.
The firm is trading with SMA20 of -0.05 Percent, SMA50 of 0.33 Percent and SMA200 of 1.66 percent. Capitol Investment Corp. IV has P/S value of 0 while its P/B value stands at 23.9. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
There is no forecast data available.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Merit Medical Systems, Inc. (NASDAQ:MMSI)
Merit Medical Systems, Inc. set out to build the world’s most customer-focused healthcare company by understanding customers’ needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit’s primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Merit Medical Systems, Inc. (NASDAQ:MMSI)’s Financial Outlook
The 10 analysts offering 12-month price forecasts for Merit Medical Systems Inc have a median target of 71.50, with a high estimate of 79.00 and a low estimate of 33.00. The median estimate represents a +34.45% increase from the last price of 53.18.
Merit Medical Systems, Inc. is estimated to report earnings on 02/27/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.45. The reported EPS for the same quarter last year was $0.33.
According to Zacks Investment Research, Merit Medical Systems, Inc. has a Consensus Recommendation of 1.63. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined -1.7% and closed its last trading session at $53.18. The company has the market capitalization of $2.97 Billion. The stock has 52-week high of $66.34 and 52-Week low of $41.55. The firm touched its 52-Week high on 66.34 and 52-Week low on 41.55. The company has volume of 278829 shares. The company has a total of 55.78 Million shares outstanding.
Merit Medical Systems, Inc. (NASDAQ) in the last quarter reported its actual EPS of $0.47/share where the analyst estimated EPS was $0.42/share. The difference between the actual and Estimated EPS is $0.05. This shows a surprise factor of 11.9 percent.
The company has YTD performance of -4.71 percent. Beta for Merit Medical Systems, Inc. stands at 1.18 while its ATR (average true range) is 2.11. The company has Weekly Volatility of 3.49%% and Monthly Volatility of 4.05%%.
Merit Medical Systems, Inc. has distance from 20-day Simple Moving Average (SMA20) of -0.43%, Distance from 50-Day Simple Moving Average of -6.82 percent and Distance from 200-Day Simple Moving Average of -3.6%.
The Company currently has ROA (Return on Assets) of 3.2 percent, Return on Equity (ROE) of 5.3 Percent and Return on Investment (ROI) of 4% with Gross margin of 44.7 percent and Operating & Profit margin of 7% and 4.7% respectively.